Head-to-head for women
CoreAge Rx vs Eve
CoreAge Rx and Eve both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Metabolic-Fit Score — our women's-health rubric.
CoreAge Rx
Higher scoreRanked #1 for women · Grade A−
Metabolic-Fit / 100
Best for: Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Visit CoreAge RxEve
Ranked #51 for women · Grade C
Metabolic-Fit / 100
Best for: Mothers who want a single, predictable price no matter which molecule they end up on, and who don't mind confirming state coverage directly before paying.
Visit EveThe verdict for women
CoreAge Rx edges out Eve on the Metabolic-Fit Score, 92 to 49 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.
Eve is still a genuine option — one flat $195/mo price for compounded GLP-1 therapy, injection or sublingual, regardless of which molecule — plus a brand-name lane (Ozempic, Wegovy, Mounjaro) for mothers who want an on-label pen instead. Its full pricing only renders inside the signup flow, and the state list isn't published. Weigh the six women's-health factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Eve |
|---|---|---|
| Metabolic-Fit Score | 92/100 · A− | 49/100 · C |
| Overall rank | #1 | #51 |
| Semaglutide | $99/mo | $195/mo flat |
| Tirzepatide | $149/mo | $195/mo flat |
| Coverage | All 50 states | Multiple states (not fully enumerated — confirm yours before signing up) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Metabolic-Fit / 100
CoreAge Rx
Ranked #1 · Grade A−
What we like
- A single flat monthly rate — no teaser first month that jumps at the first refill
- A prescriber reviews your history and will actually talk through timing if you're postpartum, nursing, or planning another pregnancy
- Semaglutide and tirzepatide on one chart, so switching molecules doesn't mean switching providers
The caveats
- Not the lowest sticker price — a couple of budget compounders come in under it
- Compounded only; there's no FDA-approved brand Wegovy or Zepbound lane here
- A general metabolic program, not a dedicated OB or hormone practice
Metabolic-Fit / 100
Eve
Ranked #51 · Grade C
What we like
- One flat $195/mo rate covers either molecule — no separate, higher tirzepatide price to plan around
- A genuine oral/sublingual compounded option at the same flat price as the injection
- Also offers brand-name Ozempic, Wegovy, and Mounjaro for mothers who want an FDA-approved pen
The caveats
- No published state list — coverage is confirmed only after you start intake or relocate
- Full per-dose pricing is gated behind the signup application, not visible on the public marketing page
- Named pharmacy, 503A/503B designation, and medical director are not disclosed anywhere public
Some outbound links earn MomMetabolic a referral fee at no added cost to you, walled off from the Metabolic-Fit Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Eve against other providers we review for women.
Or browse the full comparison hub.